A Genetic Modifier of the Gut Microbiome Influences the Risk of Graft-versus-Host Disease and Bacteremia After Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 22, Issue 3, 2016, Pages 418-422

  Rayes, Ahmad ^a   Morrow, Ardythe L ^a   Payton, Leslie R ^a   Lake, Kelly E ^a   Lane, Adam ^a   Davies, Stella M ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Bacteremia; Fucosyltransferase 2; FUT2; Graft versus host disease; Hematopoietic stem cell transplantation; Microbiome

Indexed keywords

FUCOSYLTRANSFERASE; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN; GALACTOSIDE 2-ALPHA-L-FUCOSYLTRANSFERASE;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BACTEREMIA; BACTERIAL TRANSLOCATION; CHILD; CLOSTRIDIUM DIFFICILE INFECTION; DNA MODIFICATION; FEMALE; GENOTYPE; GRAFT VERSUS HOST REACTION; HUMAN; INTESTINE FLORA; INTESTINE MUCOSA; MAJOR CLINICAL STUDY; MALE; NOROVIRUS INFECTION; OVERALL SURVIVAL; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; ALLOGRAFT; CLINICAL TRIAL; ENZYMOLOGY; FACTUAL DATABASE; GENETICS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; INFANT; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ALLOGRAFTS; BACTEREMIA; BACTERIAL TRANSLOCATION; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; FUCOSYLTRANSFERASES; GASTROINTESTINAL MICROBIOME; GENOTYPE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; RISK FACTORS;

EID: 84954285995     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2015.11.017     Document Type: Article

References (33)

1. 1 Jenq, R.R., Ubeda, C., Taur, Y., et al. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med 209 (2012), 903–911.
2. 2 McGuckin, M.A., Lindén, S.K., Sutton, P., Florin, T.H., Mucin dynamics and enteric pathogens. Nat Rev Microbiol 9 (2011), 265–278.
3. 3 Cornick, S., Tawiah, A., Chadee, K., Roles and regulation of the mucus barrier in the gut. Tissue Barriers, 3, 2015 e982426.
4. 4 Sperandio, B., Fischer, N., Sansonetti, P.J., Mucosal physical and chemical innate barriers: Lessons from microbial evasion strategies. Semin Immunol 27 (2015), 111–118.
5. 5 Lee, Y.K., Mazmanian, S.K., Has the microbiota played a critical role in the evolution of the adaptive immune system?. Science 330 (2010), 1768–1773.
6. 6 Rouquier, S., Lowe, J.B., Kelly, R.J., et al. Molecular cloning of a human genomic region containing the H blood group alpha(1,2)fucosyltransferase gene and two H locus-related DNA restriction fragments. Isolation of a candidate for the human Secretor blood group locus. J Biol Chem 270 (1995), 4632–4639.
7. 7 Hoskins, L.C., Agustines, M., McKee, W.B., et al. Mucin degradation in human colon ecosystems. Isolation and properties of fecal strains that degrade ABH blood group antigens and oligosaccharides from mucin glycoproteins. J Clin Invest 75 (1985), 944–953.
8. 8 Moulds, J.M., Nowicki, S., Moulds, J.J., Nowicki, B.J., Human blood groups: incidental receptors for viruses and bacteria. Transfusion 36 (1996), 362–374.
9. 9 Wacklin, P., Mäkivuokko, H., Alakulppi, N., et al. Secretor genotype (FUT2 gene) is strongly associated with the composition of bifidobacteria in the human intestine. PLoS One, 6, 2011 e20113.
10. 10 Rausch, P., Rehman, A., Künzel, S., et al. Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype. Proc Natl Acad Sc U S A 108 (2011), 19030–19035.
11. 11 Tong, M., McHardy, I., Ruegger, P., et al. Reprograming of gut microbiome energy metabolism by the FUT2 Crohn's disease risk polymorphism. ISME J 8 (2014), 2193–2206.
12. 12 Kelly, R.J., Rouquier, S., Giorgi, D., et al. Sequence and expression of a candidate for the human secretor blood group α(1,2)Fucosyltransferase Gene (FUT2). J Biol Chem 270 (1995), 4640–4649.
13. 13 Koda, Y., Soejima, M., Kimura, H., The polymorphisms of fucosyltransferases. Leg Med (Tokyo) 3 (2001), 2–14.
14. 14 McGovern, D.P.B., Jones, M.R., Taylor, K.D., et al. Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease. Hum Mol Genet 19 (2010), 3468–3476.
15. 15 Choi, S.W., Levine, J.E., Ferrara, J.L., Pathogenesis and management of graft-versus-host disease. Immunol Allergy Clin North Am 30 (2010), 75–101.
16. 16 Pickard, J.M., Maurice, C.F., Kinnebrew, M.A., et al. Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness. Nature 514 (2014), 638–641.
17. 17 Kinane, D.F., Blackwell, C.C., Brettle, R.P., et al. ABO blood group, secretor state, and susceptibility to recurrent urinary tract infection in women. Br Med J (Clin Res Ed) 285 (1982), 7–9.
18. 18 Sheinfeld, J., Schaeffer, A.J., Cordon-Cardo, C., et al. Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. N Engl J Med 320 (1989), 773–777.
19. 19 Stapleton, A., Nudelman, E., Clausen, H., et al. Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status. J Clin Invest 90 (1992), 965–972.
20. 20 Blackwell, C.C., Jonsdottir, K., Hanson, M., et al. Non-secretion of ABO antigens predisposing to infection by Neisseria meningitidis and Streptococcus pneumoniae. Lancet 2 (1986), 284–285.
21. 21 Blackwell, C.C., Jonsdottir, K., Hanson, M.F., Weir, D.M., Non-secretion of ABO blood group antigens predisposing to infection by Haemophilus influenzae. Lancet, 20, 1986, 687.
22. 22 Lee, S.J., Klein, J., Haagenson, M., et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 110 (2007), 4576–4583.
23. 23 Glucksberg, H., Storb, R., Fefer, A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation, 18, 1974, 295.
24. 24 Fine, J.P., Gray, R.J., Proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94 (1999), 496–509.
25. 25 Morrow, A.L., Meinzen-Derr, J., Huang, P., et al. Fucosyltransferase 2 non-secretor and low secretor status predicts severe outcomes in premature infants. J Pediatr 158 (2011), 745–751.
26. 26 Pham, T.A.N., Clare, S., Goulding, D., et al. Epithelial IL-22RA1-mediated fucosylation promotes intestinal colonization resistance to an opportunistic pathogen. Cell Host Microbe 16 (2014), 504–516.
27. 27 Maroni, L., van de Graaf, S.F.J., Hohenester, S.D., et al. Fucosyltransferase 2: a genetic risk factor for primary sclerosing cholangitis and Crohn's disease—a comprehensive review. Clin Rev Allergy Immunol 48 (2014), 182–191.
28. 28 Wacklin, P., Tuimala, J., Nikkilä, J., et al. Faecal microbiota composition in adults is associated with the FUT2 gene determining the secretor status. PLoS One, 9, 2014 e94863.
29. 29 Taur, Y., Jenq, R.R., Perales, M.-A., et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood 124 (2014), 1174–1182.
30. 30 Thorven, M., Grahn, A., Hedlund, K.-O., et al. A homozygous nonsense mutation (428G→A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections. J Virol 79 (2005), 15351–15355.
31. 31 Carlsson, B., Kindberg, E., Buesa, J., et al. The G428A nonsense mutation in FUT2 provides strong but not absolute protection against symptomatic GII.4 Norovirus infection. PLoS One, 4, 2009 e5593.
32. 32 Currier, R.L., Payne, D.C., Staat, M.A., et al. Innate susceptibility to norovirus infections influenced by FUT2 genotype in a United States pediatric population. Clin Infect Dis 60 (2015), 1631–1638.
33. 33 Gock, H., Murray-Segal, L.J., Winterhalter, A.C., et al. Altered glycosylation in donor mice causes rejection of strain-matched skin and heart grafts. Am J Transplant 14 (2014), 797–805.